Perspectives for the treatment of hepatitis B virus infections

This publication has 65 references indexed in Scilit:

• Use of digoxigenin-labelled probes for the quantitation of HBV-DNA in antiviral drug evaluation
  Journal of Virological Methods, 1999
• Long-Term Therapy with the Guanine Nucleoside Analog Penciclovir Controls Chronic Duck Hepatitis B Virus Infection In Vivo
  Antimicrobial Agents and Chemotherapy, 1998
• A One-Year Trial of Lamivudine for Chronic Hepatitis B
  New England Journal of Medicine, 1998
• Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus
  Antimicrobial Agents and Chemotherapy, 1997
• Anti-HIV and Anti-HBV Activity and Resistance Profile of 2′,3′-Dideoxy-3′-Thiacytidine (3TC) and Its Arylphosphoramidate Derivative CF 1109
  Biochemical and Biophysical Research Communications, 1996
• Design and Synthesis of 2‘,3‘-Dideoxy- 2‘,3‘-didehydro-β-l-cytidine (β-l-d4C) and 2‘,3‘-Dideoxy-2‘,3‘-didehydro-β-l-5- fluorocytidine (β-l-Fd4C), Two Exceptionally Potent Inhibitors of Human Hepatitis B Virus (HBV) and Potent Inhibitors of Human Immunodeficiency Virus (HIV) in Vitro
  Journal of Medicinal Chemistry, 1996
• The in vitro anti-hepatitis B virus activity of FIAU [1-(2′-deoxy-2′-fluoro-1-β-d-arabinofuranosyl-5-iodo)uracil] is selective, reversible, and determined, at least in part, by the host cell
  Antiviral Research, 1994
• The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
  Antimicrobial Agents and Chemotherapy, 1992
• Inhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesis
  Antimicrobial Agents and Chemotherapy, 1991
• THE MOLECULAR BIOLOGY OF THE HEPATITIS B VIRUSES
  Annual Review of Biochemistry, 1987